PALO ALTO, Calif., May 13, 2015 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) is announcing that financing for the Maryland Proton Therapy Center (MPTC) was completed today. The MPTC project is being financed by parties including Deutsche Bank AG, Varian, and several private investors. Varian has committed to loan up to $35 million to the project through its subsidiary in Switzerland. Varian's commitment is in the form of a subordinated loan that is due, with accrued interest, in three annual payments from 2020 to 2022.
